Wealth Enhancement Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,000
Closed -$127K 2667
2024
Q1
$127K Buy
+14,000
New +$1.19M ﹤0.01% 2266

Other funds holding MDT

Wealth Enhancement Advisory Services's MDT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Medtronic (MDT) stake by 21% in Q2 2026, buying an estimated $12.8M and bringing the position to 921,461 shares worth $69.7M. The position accounts for 0.12% of the portfolio, ranked #160.

Wealth Enhancement Advisory Services first reported a position in MDT in Q4 2018 and has held it in 16 quarters since. The position peaked at $86.1M in Q4 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Wealth Enhancement Advisory Services held 921,461 shares of Medtronic worth $69.7M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 158,322 Medtronic shares in Q2 2026, an estimated $12.8M.
  • Medtronic made up 0.12% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #160 holding.
  • Wealth Enhancement Advisory Services first reported a position in Medtronic in Q4 2018 and has held it in 16 quarters since.
  • Wealth Enhancement Advisory Services's Medtronic position peaked at $86.1M in Q4 2025.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.